REGENXBIO Inc.
DE ˙ DB ˙ US75901B1070
6,20 € ↓ -0,10 (-1,59%)
2026-06-02
PREZZO DELLE AZIONI
SecurityDE:RB0 / REGENXBIO Inc.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership12,410 shares
Latest Disclosed Value $ 103,996
Prudential Financial Inc ownership in RB0 / REGENXBIO Inc.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 12,410 shares of REGENXBIO Inc. (DE:RB0) valued at $85,629 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 13, 2025 disclosing 0 shares of REGENXBIO Inc.. The current value of the position is $76,942 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F REGENXBIO COM 75901B107 12,410 12,410 104 0.0001
2025-11-13 2025-09-30 13F REGENXBIO COM 75901B107 0 -10,631 -100.00 0 -100.00
2025-08-12 2025-06-30 13F REGENXBIO COM 75901B107 10,631 10,631 87 0.0001
2025-02-11 2024-12-31 13F REGENXBIO COM 75901B107 0 -48,769 -100.00 0 -100.00
2024-11-14 2024-09-30 13F REGENXBIO COM 75901B107 48,769 -2,600 -5.06 512 -14.98 0.0007
2024-08-13 2024-06-30 13F REGENXBIO COM 75901B107 51,369 1,345 2.69 601 -42.98 0.0009
2024-05-14 2024-03-31 13F REGENXBIO COM 75901B107 50,024 2,880 6.11 1,054 24.59 0.0015
2024-02-13 2023-12-31 13F REGENXBIO COM 75901B107 47,144 -276 -0.58 846 8.46 0.0013
2023-11-13 2023-09-30 13F REGENXBIO COM 75901B107 47,420 -21,250 -30.95 781 -43.15 0.0012
2023-08-11 2023-06-30 13F REGENXBIO COM 75901B107 68,670 -2,742 -3.84 1,373 1.63 0.0020
2023-05-12 2023-03-31 13F REGENXBIO COM 75901B107 71,412 800 1.13 1,350 -15.68 0.0021
2023-02-14 2022-12-31 13F REGENXBIO COM 75901B107 70,612 20,545 41.04 1,601 21.01 0.0027
2022-11-04 2022-09-30 13F REGENXBIO COM 75901B107 50,067 -40,285 -44.59 1,323 -40.73 0.0022
2022-08-15 2022-06-30 13F REGENXBIO COM 75901B107 90,352 50,885 128.93 2,232 70.38 0.0035
2022-05-13 2022-03-31 13F REGENXBIO COM 75901B107 39,467 -3,014 -7.09 1,310 -5.69 0.0017
2022-02-14 2021-12-31 13F REGENXBIO COM 75901B107 42,481 743 1.78 1,389 -20.63 0.0017
2021-11-15 2021-09-30 13F REGENXBIO COM 75901B107 41,738 2,739 7.02 1,750 15.51 0.0024
2021-08-16 2021-06-30 13F REGENXBIO COM 75901B107 38,999 -1,131 -2.82 1,515 10.66 0.0021
2021-05-12 2021-03-31 13F REGENXBIO COM 75901B107 40,130 5,710 16.59 1,369 -12.30 0.0021
2021-08-16 2020-12-31 13F/A-1 REGENXBIO COM 0045 75901B107 34,420 -640 -1.83 1,561 61.76 0.0026
2021-02-16 2020-12-31 13F REGENXBIO COM 75901B107 34,420 -640 1,561 0.0026
2020-11-16 2020-09-30 13F REGENXBIO COM 75901B107 35,060 -2,680 -7.10 965 -30.58 0.0018
2020-08-12 2020-06-30 13F REGENXBIO COM 75901B107 37,740 -11,440 -23.26 1,390 -12.69 0.0027
2020-05-12 2020-03-31 13F REGENXBIO COM 75901B107 49,180 -1,864 -3.65 1,592 -23.86 0.0035
2020-02-11 2019-12-31 13F REGENXBIO COM 75901B107 51,044 -6,036 -10.57 2,091 2.90 0.0031
2019-11-13 2019-09-30 13F REGENXBIO COM 75901B107 57,080 -57,060 -49.99 2,032 -65.35 0.0032
2019-08-08 2019-06-30 13F REGENXBIO COM 75901B107 114,140 7,200 6.73 5,864 -4.32 0.0091
2019-05-15 2019-03-31 13F REGENXBIO COM 75901B107 106,940 -43,830 -29.07 6,129 -3.08 0.0102
2019-02-07 2018-12-31 13F REGENXBIO COM 75901B107 150,770 700 0.47 6,324 -44.18 0.0111
2018-11-07 2018-09-30 13F REGENXBIO COM 75901B107 150,070 4,310 2.96 11,330 8.34 0.0167
2018-08-13 2018-06-30 13F REGENXBIO COM 75901B107 145,760 111,850 329.84 10,458 933.40 0.0156
2018-05-04 2018-03-31 13F REGENXBIO COM 75901B107 33,910 10,560 45.22 1,012 30.41 0.0015
2018-02-13 2017-12-31 13F REGENXBIO COM 75901B107 23,350 23,350 776 0.0011
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.